Drugs and Medicines

Trump has yet to deliver on promised healthcare savings

Earlier this year, the Trump administration proposed a rule that would have ensured tens of billions of dollars of hidden rebates and discounts went to patients. Sadly, the White House just chose to abandon this sensible, bipartisan reform.

It's a shame President Trump did not see this effort through. Millions of patients would have benefited from a change in the form of lower pharmacy bills and better health outcomes.

The rule affected Medicare Part D, the federal prescription drug benefit for roughly 45 million seniors. Under Part D, private insurers compete to sell prescription drug plans to Medicare beneficiaries. The government subsidizes and regulates these plans, but...